Method for calculating fractal dimension of microvessels of tissue
A technology of fractal dimension and calculation method, which is applied in the field of medical digital image analysis, can solve the problems that the calculation method of tissue microvascular fractal dimension has not yet been established, and achieve the effect of small error, simple calculation and effective reflection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1 Calculation method of fractal dimension of microvessels in glioma tissue
[0037] 1. Calculation of fractal dimension of microvessels in glioma tissue
[0038] according to figure 1 The shown flow chart calculates the fractal dimension of microvessels in glioma tissue, and the specific steps are as follows:
[0039] (1) Use a microtome to perform routine slices of the tissue to be inspected to obtain tissue slices;
[0040] (2) Perform anti-CD34 immunohistochemical staining on the tissue section obtained in step (1) to mark blood vessels (using DAB chromogenic method) to obtain a stained section, and then use a slice panoramic scanner to scan to obtain a digital section;
[0041] (3) Intercept 3-5 "hot spots" containing the most abundant microvessels from the digital slice obtained in step (2), the image pixels are 1920 * 1080, and named as image A;
[0042](4) Use the image analysis software Image J 1.46s on the image A obtained in step (3), extract the po...
Embodiment 2
[0050] Example 2 Application of Microvessel Fractal Dimension in Glioma Tissue
[0051] From 2006 to 2012, 83 patients with glioblastoma (56 cases from Chongqing Southwest Hospital, 27 cases from Beijing Tiantan Hospital) pathological tissue sections and clinical follow-up data were collected, statistically analyzed and mvFD values were calculated and survival analysis was performed. The results are as follows: Figure 4 and Figure 5 As shown, the overall survival of patients with mvFD>1.06 glioblastoma ( Figure 4 A) and progression-free survival ( Figure 4 B) are significantly larger than those in patients with mvFD≤1.06. Among glioblastoma patients receiving chemotherapy, the progression-free survival of patients with mvFD>1.06 was significantly longer than that of patients with mvFD≤1.06, suggesting that mvFD>1.06 can be used as a standard for good chemotherapy response in glioblastoma patients ( Figure 5 A). Among patients who did not receive chemotherapy, there ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 